Cargando…

A Novel Standard for Hepatocellular Carcinoma Screening Intensity After Hepatitis C Elimination

PURPOSE: To investigate long-term incidence of hepatocellular carcinoma (HCC) and the factors associated with HCC occurrence after achieving sustained virological response (SVR) by direct-acting antiviral agent (DAA) treatment for hepatitis C virus (HCV). METHODS: A total of 476 patients (male 227,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyasaka, Akio, Yoshida, Yuichi, Suzuki, Akiko, Sawara, Kei, Takikawa, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636695/ https://www.ncbi.nlm.nih.gov/pubmed/34866934 http://dx.doi.org/10.2147/IJGM.S344492

Ejemplares similares

Safety and efficacy of glecaprevir and pibrentasvir in north Tohoku Japanese patients with genotype 1/2 hepatitis C virus infection
por: Miyasaka, Akio, et al.
Publicado: (2022)

Health-related quality of life in patients with chronic hepatitis C treated with sofosbuvir-based treatment at 1-year post-sustained virological response
por: Miyasaka, Akio, et al.
Publicado: (2021)

The Real-world Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir for Hepatitis C Genotype 1
por: Miyasaka, Akio, et al.
Publicado: (2018)

Hepatitis B virus reactivation after successful treatment of hepatitis C virus with sofosbuvir and ribavirin: A case report and literature review
por: Miyasaka, Akio, et al.
Publicado: (2020)

Fatal acute hepatic failure in a family infected with the hepatitis A virus subgenotype IB: A case report
por: Yoshida, Yuichi, et al.
Publicado: (2017)

Next-generation sequencing analysis of the human T-cell and B-cell receptor repertoire diversity before and after hepatitis B vaccination
por: Miyasaka, Akio, et al.
Publicado: (2019)

Hepatitis B Surface Antibody Titers at One and Two Years after Hepatitis B Virus Vaccination in Healthy Young Japanese Adults
por: Kakisaka, Keisuke, et al.
Publicado: (2019)

Impact of Grip Strength in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib
por: Endo, Kei, et al.
Publicado: (2020)

Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma
por: Kuorda, Hidekatsu, et al.
Publicado: (2019)

Decreased Mean Kurtosis in the Putamen is a Diagnostic Feature of Minimal Hepatic Encephalopathy in Patients with Cirrhosis
por: Sato, Takuro, et al.
Publicado: (2019)

Comparing the Safety and Efficacy of Microwave Ablation Using Thermosphere(TM) Technology versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Propensity Score-Matched Analysis
por: Kuroda, Hidekatsu, et al.
Publicado: (2021)

Hepatic Angiomyolipoma Staining in the Post-vascular Phase of Contrast-enhanced Ultrasound Due to the Presence of Macrophages
por: Endo, Kei, et al.
Publicado: (2017)

Hepatocellular Carcinoma Prevention in the Era of Hepatitis C Elimination
por: Lazarus, Jeffrey V., et al.
Publicado: (2023)

Annual changes in grip strength and skeletal muscle mass in chronic liver disease: observational study
por: Endo, Kei, et al.
Publicado: (2023)

Conservative treatment of an aortoesophagial fistula after endovascular stent grafting for a thoracic aortic aneurysm
por: Kasai, Kazuhiro, et al.
Publicado: (2011)

A 55-Year-Old Japanese Man with Multiple Sclerosis Diagnosed with Disseminated Tuberculosis Identified by Liver Function Abnormalities: A Case Report
por: Miyasaka, Akio, et al.
Publicado: (2021)

A 51-Year-Old Woman with Drug-Induced Hypersensitivity Syndrome Associated with Carbamazepine, Reactivation of Human Herpesvirus 6, and Acute Liver Failure: A Case Report
por: Miyasaka, Akio, et al.
Publicado: (2021)

Hypovascular tumors developed into hepatocellular carcinoma at a high rate despite the elimination of hepatitis C virus by direct-acting antivirals
por: Tabu, Kazuaki, et al.
Publicado: (2020)

Hepatitis C: Standard of Treatment and What to Do for Global Elimination
por: Di Marco, Lorenza, et al.
Publicado: (2022)

Regulation of transforming growth factor is involved in the efficacy of combined 5-fluorouracil and interferon alpha-2b therapy of advanced hepatocellular carcinoma
por: Okada, Youhei, et al.
Publicado: (2018)

Viral elimination is essential for improving surgical outcomes of hepatitis C virus‐related hepatocellular carcinoma: Multicenter retrospective analysis
por: Nakajima, Masao, et al.
Publicado: (2020)

Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells
por: Saito, Tomoko, et al.
Publicado: (2013)

Screening for Hepatocellular Carcinoma in Patients with Hepatitis B
por: Sachar, Yashasavi, et al.
Publicado: (2021)

Acute liver failure precipitated by acute Budd‐Chiari syndrome and complete portal vein thrombosis
por: Suzuki, Yuji, et al.
Publicado: (2021)

Carbon-ion radiotherapy subsequent to balloon-occluded retrograde transvenous obliteration for hepatocellular carcinoma with hepatic encephalopathy: a multidisciplinary approach
por: Osu, Naoto, et al.
Publicado: (2021)

Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030?
por: Amponsah-Dacosta, Edina
Publicado: (2021)

Hepatocellular Carcinoma Risk, Outcomes, and Screening After Hepatitis C Eradication
por: D’Ambrosio, Roberta, et al.
Publicado: (2021)

Alterations in Hepatocellular Carcinoma-Specific Immune Responses Following Hepatitis C Virus Elimination by Direct-Acting Antivirals
por: Li, Shihui, et al.
Publicado: (2022)

Early serum screening for hepatocellular-carcinoma in patients with hepatitis
por: Neguț, Alina Cristina, et al.
Publicado: (2014)

Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update
por: Lok, James, et al.
Publicado: (2021)

Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral
por: Matsumae, Takayuki, et al.
Publicado: (2023)

Single-Nucleotide Resolution Mapping of Hepatitis B Virus Promoters in Infected Human Livers and Hepatocellular Carcinoma
por: Altinel, Kübra, et al.
Publicado: (2016)

Immune Checkpoint Inhibitor-Related Pneumonia in Unresectable Hepatocellular Carcinoma: Two Fatal Cases under Atezolizumab plus Bevacizumab
por: Endo, Kei, et al.
Publicado: (2022)

The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan
por: Enomoto, Hirayuki, et al.
Publicado: (2020)

The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma Treatment
por: Mori, Yuki, et al.
Publicado: (2022)

Hepatitis C Virus Elimination Using Direct Acting Antivirals after the Radical Cure of Hepatocellular Carcinoma Suppresses the Recurrence of the Cancer
por: Kuromatsu, Ryoko, et al.
Publicado: (2022)

Hepatitis C virus to hepatocellular carcinoma
por: Jahan, Shah, et al.
Publicado: (2012)

Hepatitis C Virus and Hepatocellular Carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2013)

Eliminating viral hepatitis C in Belgium: the micro-elimination approach
por: Busschots, Dana, et al.
Publicado: (2020)

Obstructive Bezoars of the Small Bowel Treated with Coca-Cola Zero through a Long Intestinal Tube and Endoscopic Manipulation
por: Endo, Kei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t48kcel8sai46993gnf4k5tu63